Hydrogen Water and Inflammation: What Clinical Trials Have Found

Most articles about hydrogen water and inflammation lead with a sweeping promise: drink this, reduce inflammation, transform your health. The peer-reviewed literature tells a more interesting story. A small but growing number of human trials have measured inflammatory markers in people drinking hydrogen-rich water — and the patterns are worth taking seriously.

This is a tour of those trials — what researchers actually measured, in which populations they measured it, over how many weeks or months, and what conclusions the published authors drew when the data came back from blood draws and transcriptional profiling and disease activity scoring across studies that range from four-week pilots in healthy adults to six-month randomized controlled trials in clinical populations.

Some findings are striking. Some are preliminary. All describe a field where the evidence base is real and the safety profile is one of the strongest in any wellness category.

Why Inflammation Became a Hydrogen Research Question

To understand why researchers started measuring inflammation in hydrogen water trials, it helps to understand the molecule. H₂ is the smallest substance in chemistry. It diffuses across cell membranes without active transport, and it does not appear to disturb the signaling roles physiological reactive oxygen species play in normal cellular processes.

That selective behavior is the hypothesis at the center of the field. It is what made researchers begin asking whether dissolved hydrogen might modulate the redox-driven inflammatory cascades that sit upstream of so many chronic conditions. Inflammation isn't one process. It's a signaling network. The question researchers have been asking is whether molecular hydrogen, by selectively reducing the most damaging reactive oxygen species, also dampens the inflammatory signals those species help trigger.

The Selective Antioxidant Hypothesis

The field of hydrogen biomedicine effectively dates to a 2007 paper in Nature Medicine. Ohsawa et al. reported that molecular hydrogen appeared to selectively neutralize the hydroxyl radical (·OH) and peroxynitrite (ONOO⁻) — the two most cytotoxic reactive oxygen species — while leaving more benign species like superoxide and hydrogen peroxide intact at physiological levels (PMID: 17486089). That selectivity matters for inflammation research, because hydroxyl radicals and peroxynitrite are precisely the species most associated with downstream inflammatory damage.

If H₂ behaves the way the Ohsawa paper proposed, it would act as a precision tool — quieting the species most associated with inflammatory cell damage without interfering with the signaling roles ROS play in normal immune function. The hypothesis is still under active investigation, but it is the framework researchers studying hydrogen water inflammation have been working within for nearly two decades.

What "Inflammation" Means in This Research

A quick clarification before the trials. When researchers measure inflammation in a hydrogen water study, they are not looking at whether someone "feels less inflamed." They are measuring specific biomarkers in blood or tissue: pro-inflammatory cytokines (IL-6, TNF-α, IL-1β), markers of immune cell activation, transcriptional pathways like NF-κB, and general indicators of systemic inflammation like erythrocyte sedimentation rate or C-reactive protein.

That distinction matters for reading the literature accurately. A trial reporting "reduced inflammatory cytokines" is reporting a measurable biological signal. The strength of the hydrogen water inflammation evidence varies depending on which marker, which population, and which trial design you are looking at.

Healthy Adults: The Korovljev 2020 Scientific Reports Trial

One of the most cited trials in this area was published in Scientific Reports in 2020 (PMID: 32699287). Thirty-eight healthy adults, 20–59, were randomized to drink either 1.5 liters per day of hydrogen-rich water or plain water for four weeks in a double-blind, placebo-controlled design.

What the Researchers Found

Using transcriptional profiling of peripheral blood mononuclear cells, the researchers reported that the hydrogen-rich water group showed significantly down-regulated networks for inflammatory responses and NF-κB signaling compared to placebo. Apoptosis of peripheral blood mononuclear cells was also significantly reduced. The authors noted that the findings were particularly pronounced in participants over 30, and they framed the data as supporting further investigation of hydrogen-enriched water as a general wellness support in healthy adults.

This was a healthy-population trial that measured molecular signals in blood. They moved in the direction the selective antioxidant hypothesis would predict — and they moved in only four weeks.

Metabolic Syndrome: 24 Weeks of Hydrogen-Rich Water

For a longer trial in a population with measurable baseline inflammation, the most informative paper is LeBaron et al. (2020), published in Diabetes, Metabolic Syndrome and Obesity (PMID: 32273740). Sixty adults with metabolic syndrome were randomized to consume high-concentration hydrogen-rich water or placebo water daily for 24 weeks — one of the longest hydrogen water RCTs in the published literature.

Alongside body composition and lipid profile changes, the researchers tracked inflammation biomarkers across the six-month protocol. They reported associations between hydrogen-rich water consumption and improvements in inflammation markers, fatty acid metabolism, glucose handling, and hemoglobin A1c compared to placebo. The authors framed these as promising findings while acknowledging that the small sample size limits the strength of definitive conclusions.

The duration is what makes this trial useful. Most hydrogen water trials run four to twelve weeks. Six months is long enough to begin distinguishing transient biological responses from sustained ones — and the inflammation markers moved in a favorable direction over that longer window.

Rheumatoid Arthritis: The Earliest Inflammation-Specific Human Studies

Some of the earliest human research connecting hydrogen and inflammation came from rheumatology. Researchers in this field were exploring selective antioxidant strategies for autoimmune-driven inflammatory cascades, and hydrogen attracted their attention quickly after the 2007 Ohsawa paper.

Ishibashi 2012 — Open-Label RA Pilot

Ishibashi et al. published an open-label pilot in Medical Gas Research in 2012 (PMID: 23031079). Twenty rheumatoid arthritis patients consumed approximately 530 mL of hydrogen water daily for four weeks. The researchers reported reductions in disease activity scores. All five participants with early-stage RA who were anti-CCP antibody negative achieved what the authors described as clinical remission during the study window — a striking finding for such a small group, even with the open-label limitations the authors themselves stressed.

Ishibashi 2014 — A Double-Blind Pilot RCT

Two years later, the same group ran a randomized double-blind placebo-controlled pilot of hydrogen-infused saline (500 mL IV daily for five days) in 24 rheumatoid arthritis patients, published in International Immunopharmacology. They reported significant improvements in DAS28 disease activity scores immediately after the infusion course and at four-week follow-up. Again — small sample, pilot design — but the data pointed in the same direction as the earlier study.

High-Altitude Inflammation: A 2025 Randomized Trial

A 2025 paper in Food Research International added to the hydrogen water inflammation literature with a double-blind randomized placebo-controlled trial of hydrogen-rich water in patients with chronic high-altitude disease — a population with sustained physiological inflammation driven by hypoxic stress.

Researchers reported significantly reduced inflammatory cytokine levels and oxidative stress markers in the hydrogen-rich water group compared to placebo. The sample size was modest, and the authors called for larger multicenter replication.

Pulmonary Inflammation: A 2024 Systematic Review

For inflammation in respiratory disease, the most useful 2024 publication is a systematic review and meta-analysis in Frontiers in Immunology on high-concentration hydrogen in lung diseases. The reviewers pooled data from human and preclinical studies examining hydrogen administration (primarily inhalation, with some hydrogen-rich water trials) in asthma, COPD, post-infection lung inflammation, and acute respiratory distress.

Across the included studies, the reviewers reported that high-concentration hydrogen was associated with reductions in pro-inflammatory cytokines, improvements in clinical symptom scores in several inflammatory lung conditions, and a favorable safety profile. The review reinforces a broader pattern in this literature: hydrogen administration is associated with measurable reductions in inflammatory signaling across multiple disease contexts.

Microinflammation in Aging Populations

Chronic low-grade inflammation — sometimes called "inflammaging" in the longevity literature — is one of the more interesting research targets for hydrogen water. A 2024 pilot observational study in the International Journal of Medical Sciences examined oral molecular hydrogen tablet supplementation in adults with chronic low-grade inflammation, reporting dose-dependent reductions in erythrocyte sedimentation rate, a general marker of systemic inflammation.

Observational, non-controlled, modest sample size — the design imposes real limits on what can be concluded. But the signal is consistent with what other trials have reported. Our overview of hydrogen water and aging research covers the longevity overlap in more depth.

The Mechanism Research: How H₂ May Quiet Inflammatory Signaling

The NF-κB Pathway

NF-κB is one of the most studied transcriptional regulators of inflammation. When activated, it drives production of pro-inflammatory cytokines, adhesion molecules, and immune cell signaling proteins. Multiple preclinical and human transcriptional studies — including the Korovljev 2020 trial — have reported associations between hydrogen-rich water consumption and reduced NF-κB pathway activity. A mechanistic review in Current Pharmaceutical Design (Ishibashi, 2013) proposed that hydrogen's effects on inflammatory disease pathways may be mediated through suppression of NF-κB and MAPK signaling cascades.

The Hydroxyl Radical Connection

The proposed link back to the Ohsawa hypothesis is straightforward. Hydroxyl radicals and peroxynitrite — the species H₂ appears to selectively reduce — are themselves potent activators of inflammatory signaling. If H₂ lowers their concentration in tissues, the downstream inflammatory cascade those species help trigger should also be quieted. That is the mechanistic story the field has been working from, and the human transcriptional data has been broadly consistent with it.

Why Equipment Quality Matters for the Inflammation Research

The trials above all share something in common: they used hydrogen-rich water with specific, measured concentrations of dissolved H₂. None of them used water containing trace amounts of hydrogen with no concentration verification.

Given these engineering criteria, here is how the Lourdes Hydrofix Premium Edition addresses them. The unit uses a separate-chamber (dual-chamber) electrolysis system with a multi-layer fibriform polymer membrane that isolates hydrogen-rich water from electrolysis byproducts. The Lourdes Hydrofix produces approximately 120 mL/min of hydrogen gas, supporting dissolved concentrations of up to approximately 1.6 ppm under normal conditions. Independent testing by Masa International Corp. (Test No. MM03-6024-01) documented output up to 134.2 mL/min under specified test conditions.

You can find the Lourdes Hydrofix in our hydrogen water machine collection.

The electrodes are high-purity titanium and platinum (TP270C, 99.928% purity per metallurgical Certificate No. 17-MANS-0078-B). Independent testing by Japan Food Research Laboratories (JFRL Certificate No. 23028707001-0201) found that selected plasticizers, BPA, iron, and titanium were not detected in the output water under the conditions tested — a level of third-party material verification most consumer hydrogen water generators do not commission, much less publish openly. Every machine ships with an individual certificate of authenticity showing the hydrogen concentration test results for that specific unit; most hydrogen water companies don't individually test every machine they ship.

Buying a hydrogen water generator will not, by itself, change your inflammation markers — no clinical trial has tested any consumer device against that endpoint. The point is that if you are going to drink hydrogen water consistently, the concentration and purity of what you are drinking is what determines whether you are getting anything close to what the trials used. For more on what separates rigorously engineered systems from lower-cost alternatives, see our hydrogen water machine buyer's guide and our explainer on separate-chamber vs. single-chamber electrolysis.

Frequently Asked Questions

Does hydrogen water reduce inflammation?

Several human trials have reported associations between hydrogen-rich water consumption and reductions in inflammatory biomarkers — pro-inflammatory cytokines, NF-κB signaling activity, and systemic inflammation markers. The Korovljev 2020 Scientific Reports trial in healthy adults, the 24-week metabolic syndrome trial, and the 2025 high-altitude trial all reported favorable changes. No hydrogen water product is approved as an anti-inflammatory therapy, and the evidence base is built primarily on small to mid-size trials. The inflammation question also runs straight into the cardiovascular research literature on hydrogen water — where inflammatory mediators like IL-6, MMP-9, and CXCL1 are the readouts the trials are measuring.

How much hydrogen water did the inflammation trials use?

The Korovljev 2020 healthy-adults trial used 1.5 liters per day for four weeks. The metabolic syndrome trial used high-concentration hydrogen water daily for 24 weeks. The Ishibashi 2012 RA pilot used approximately 530 mL per day for four weeks. Across the literature, daily volumes have ranged from about 500 mL to 1.5 liters, and durations from a few weeks to six months. For day-to-day use, many users drink approximately two liters per day — often two large glasses first thing in the morning.

Is hydrogen water safe to drink long-term?

The published trials, including the 24-week Nutrients trial in metabolic syndrome, have not reported significant adverse effects at the volumes studied. Hydrogen gas is classified as Generally Recognized as Safe (GRAS) by the FDA when present in water. People with diagnosed inflammatory conditions or who take prescription medications should consult their healthcare provider before adding any new wellness practice.

Further Reading

For the broader peer-reviewed literature on hydrogen water and inflammation, see PubMed's filtered results. The papers below are the ones we found most useful while writing this article — each entry summarizes what the study actually reported, in plain language.

• Sim et al., Korovljev group (2020), Scientific Reports. PMID: 32699287. A four-week, double-blind, placebo-controlled trial in 38 healthy adults drinking 1.5 liters per day of hydrogen-rich water. Using transcriptional profiling of blood cells, the researchers found that inflammatory-response networks and NF-κB signaling were down-regulated in the hydrogen group compared to placebo. The signal was most pronounced in participants over age 30. A useful entry point for what hydrogen water does in people who are not already sick.
• LeBaron et al. (2020), Diabetes, Metabolic Syndrome and Obesity. PMID: 32273740. One of the longest hydrogen water RCTs published — 24 weeks in 60 adults with metabolic syndrome. The authors reported that hydrogen-rich water consumption was associated with improvements in inflammation markers, lipid profile, fatty acid metabolism, and glycemic control compared to placebo. Read it for the duration as much as the findings: most hydrogen water trials end well before six months.
• Ishibashi et al. (2012), Medical Gas Research. PMID: 23031079. The earliest human inflammation-focused hydrogen water study — an open-label pilot in 20 rheumatoid arthritis patients drinking about 530 mL of hydrogen water daily for four weeks. Disease activity scores fell across the cohort, and all five anti-CCP-negative early-stage patients reached what the authors described as clinical remission during the study window. A small, unblinded pilot, but the paper that pulled hydrogen into rheumatology.
• Ishibashi (2013), Current Pharmaceutical Design. PMC3788323. A mechanistic review of how molecular hydrogen may modulate inflammatory disease pathways. The review argues that hydrogen's anti-inflammatory effects in rheumatoid arthritis and related conditions appear mediated through suppression of NF-κB and MAPK signaling — the same transcriptional networks the human trials have been measuring. A good companion paper to the Ishibashi clinical pilots above.
• Anti-inflammatory and antioxidant activity of high concentrations of hydrogen in lung diseases: a systematic review and meta-analysis (2024), Frontiers in Immunology. PMID: 39211045. The most comprehensive recent synthesis of hydrogen administration data in respiratory inflammation. Across the included human and preclinical studies, the reviewers reported reductions in pro-inflammatory cytokines, improvements in clinical symptom scores in several inflammatory lung conditions, and a favorable safety profile. The clearest single-paper overview of the inflammation literature in lung disease.
• Ohsawa et al. (2007), Nature Medicine. PMID: 17486089. The foundational paper. Ohsawa's group reported that molecular hydrogen appeared to selectively neutralize the hydroxyl radical and peroxynitrite while leaving more benign reactive oxygen species alone. The hypothesis that opened the door to two decades of inflammation research — including most of the trials summarized above. Read it for the mechanism story everything else has been built on.

References

1. Ohsawa, I., Ishikawa, M., Takahashi, K., et al. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine, 13(6), 688–694. PMID: 17486089.
2. Sim, M., Kim, C.S., Shon, W.J., et al. (2020). Hydrogen-rich water reduces inflammatory responses and prevents apoptosis of peripheral blood cells in healthy adults: a randomized, double-blind, controlled trial. Scientific Reports, 10, 12130. PMID: 32699287.
3. LeBaron et al. (2020). The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome. Diabetes, metabolic syndrome and obesity. DOI: 10.2147/DMSO.S240122. PMID: 32273740.
4. Ishibashi, T., Sato, B., Rikitake, M., et al. (2012). Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Medical Gas Research, 2, 27. PMID: 23031079.
5. Ishibashi, T., Sato, B., Shibata, S., et al. (2014). Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study. International Immunopharmacology, 21(2), 468–473.
6. Ishibashi, T. (2013). Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases. Current Pharmaceutical Design, 19(35), 6375–6381. PMC3788323.
7. Hydrogen-rich water supplementation attenuates oxidative stress and inflammation in chronic high-altitude disease patients: a double-blind randomized placebo-controlled study. (2025). Food Research International. ScienceDirect: S0963996925014565.
8. Anti-inflammatory and antioxidant activity of high concentrations of hydrogen in the lung diseases: a systematic review and meta-analysis. (2024). Frontiers in Immunology. DOI: 10.3389/fimmu.2024.1444958.
9. Using oral molecular hydrogen supplements to combat microinflammation in humans: a pilot observational study. (2024). International Journal of Medical Sciences, 21, 2390.

Related reading: For the broader picture of what the hydrogen water research base demonstrates, see our review of what the research shows. For the engineering side — what determines whether your machine actually delivers the concentrations the trials used — start with our buyer's guide.

Holy Hydrogen products, including the Lourdes Hydrofix Premium Edition, are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.